title: Evidence underlying the clinical management of diabetic macular oedema.
abstract: Diabetic retinopathy (DR) is the leading cause of visual loss in the developed world in those of working age, and its prevalence is predicted to double by 2025. The management of diabetic retinopathy has traditionally relied on screening, on laser treatment delivered by ophthalmologists, and on optimising blood glucose and blood pressure. Recent evidence suggests that the role of systemic factors is more complex than originally thought, and that drugs such as ACE inhibitors, fibrates and glitazones may all influence the course of diabetic macular oedema. Antagonism of vascular endothelial growth factor offers a new therapeutic avenue that may transform the management of diabetic macular oedema. Several other therapeutic options are under investigation and development, including aminoguanidine, sorbinol, ruboxistaurin and autologous stem cell transfusion.
authors.affiliation: Belfast Health and Social Care Trust, UK. mwilliams11@qub.ac.uk
authors.forename: Michael Andrew
authors.initials: MA
authors.lastname: Williams
authors.forename: Usha
authors.initials: U
authors.lastname: Chakravarthy
mesh_terms: D003930:Diabetic Retinopathy / Q000150:complications*; D003937:Diagnosis, Differential; D019468:Disease Management; D006801:Humans; D008269:Macular Edema / Q000175:diagnosis / Q000209:etiology / Q000628:therapy
keywords: Retinopathy; diabetes; macular
references.citation: Lancet. 2008 Oct 18;372(9647):1394-402
references.pmid: 18823656
references.citation: Lancet. 2008 Oct 18;372(9647):1385-93
references.pmid: 18823658
references.citation: Arch Ophthalmol. 2012 Aug;130(8):972-9
references.pmid: 22491395
references.citation: Invest Ophthalmol Vis Sci. 2011 Feb 28;52(2):1156-63
references.pmid: 21357409
references.citation: Diabetes Care. 2008 Apr;31(4):761-3
references.pmid: 18184895
references.citation: J Assoc Physicians India. 2011 Apr;59 Suppl:8-12
references.pmid: 21818992
references.citation: Evid Based Med. 2011 Apr;16(2):45-6
references.pmid: 21427054
references.citation: Lancet. 2000 Jan 22;355(9200):253-9
references.pmid: 10675071
references.citation: Invest Ophthalmol Vis Sci. 2010 Oct;51(10):4867-74
references.pmid: 20876889
references.citation: BMJ. 1998 Sep 12;317(7160):703-13
references.pmid: 9732337
references.citation: Arch Ophthalmol. 1990 Sep;108(9):1234-44
references.pmid: 2119168
references.citation: N Engl J Med. 1993 Sep 30;329(14):977-86
references.pmid: 8366922
references.citation: Invest Ophthalmol Vis Sci. 2008 Jun;49(6):2679-85
references.pmid: 18362112
references.citation: Am J Nephrol. 2004 Jan-Feb;24(1):32-40
references.pmid: 14685005
references.citation: Mol Biol Cell. 2010 Feb 1;21(3):377-9
references.pmid: 20124007
references.citation: Arch Ophthalmol. 2009 Mar;127(3):245-51
references.pmid: 19273785
references.citation: N Engl J Med. 2008 Jun 12;358(24):2630-3
references.pmid: 18539918
references.citation: PLoS One. 2008;3(11):e3554
references.pmid: 18978936
references.citation: Lancet. 1998 Sep 12;352(9131):837-53
references.pmid: 9742976
references.citation: Prog Retin Eye Res. 2011 May;30(3):149-66
references.pmid: 21352947
references.citation: Eye (Lond). 2009 Jul;23(7):1496-508
references.pmid: 19444297
references.citation: Eye (Lond). 2011 Jul;25(7):843-9
references.pmid: 21436845
references.citation: Arch Soc Esp Oftalmol. 2007 Apr;82(4):209-18
references.pmid: 17443425
references.citation: Ophthalmology. 2011 Apr;118(4):609-14
references.pmid: 21459214
references.citation: Eye (Lond). 2010 Jan;24(1):1-6
references.pmid: 19648902
references.citation: Eye (Lond). 2004 Aug;18(8):826-32
references.pmid: 14976547
references.citation: Eye (Lond). 2011 Jul;25(7):851-8; quiz 859
references.pmid: 21587271
references.citation: Am J Ophthalmol. 2011 Sep;152(3):329-331
references.pmid: 21855670
references.citation: BMJ. 1989 Nov 11;299(6709):1198-201
references.pmid: 2513049
references.citation: Ophthalmology. 1991 May;98(5 Suppl):766-85
references.pmid: 2062512
references.citation: Arch Ophthalmol. 2010 Mar;128(3):312-8
references.pmid: 20212201
references.citation: Eur J Ophthalmol. 2011;21 Suppl 6:S10-9
references.pmid: 23264324
references.citation: Exp Diabetes Res. 2007;2007:61038
references.pmid: 18224243
references.citation: Ophthalmology. 2011 Sep;118(9):1819-26
references.pmid: 21546089
references.citation: Diabetes Care. 2012 Mar;35(3):556-64
references.pmid: 22301125
references.citation: Retina. 2011 Jun;31(6):1053-9
references.pmid: 21386766
references.citation: Lancet. 1998 Jan 3;351(9095):28-31
references.pmid: 9433426
references.citation: Lancet. 2007 Nov 17;370(9600):1687-97
references.pmid: 17988728
references.citation: N Engl J Med. 2008 Feb 7;358(6):580-91
references.pmid: 18256393
references.citation: Semin Ophthalmol. 2010 Sep-Nov;25(5-6):192-7
references.pmid: 21090999
references.citation: Lancet. 2004 Aug 21-27;364(9435):685-96
references.pmid: 15325833